Congratulations to all the authors whose work is featured in our latest special collection. Curating this collection has been a thoroughly enjoyable experience! The vast diversity of therapeutic/ diagnostic modalities is simply amazing & humbling at the same time.
Thank you to everyone who joined us for the insightful Careers in Industry Round Table! Special thanks to our outstanding speakers @ApoorvaSarode and @BenhabbourS for sharing their industry expertise and answering all our questions.
Have you been thinking about a career in industry and want to know more? If so, our Careers in Industry Roundtable is the event for you! Come and ask your questions to our outstanding speakers @ApoorvaSarode and @BenhabbourS#CRS2024@CRSScience
👇Check out this outstanding collection of research in @BioconjChem recently published by industrial authors! A special thanks to @ApoorvaSarode (@genentech), one of our fabulous Topic Editors, for organizing this virtual issue! 👏
Meet Your Plenary Speaker!
Register for #CRS2024: 👉https://t.co/Dy8lTYp48L
Laura Sepp-Lorenzino, Ph.D. is the Chief Scientific Officer at Intellia Therapeutics and a recognized expert on nucleic acid therapies R+D. Don't miss out on her lecture, register today!
#crs#pharma
CALL FOR PAPERS @BioconjChem@Theresa_Reineke : We are delighted to announce that Bioconjugate Chemistry will publish a special issue on Brain Targeted Drug Delivery. We invite researchers to share their recent discoveries in this specialized area. https://t.co/w9FIaU0Ovl
So excited to join the editorial team of Bioconjugate Chemistry as the first topic editor from industry! Together, we hope to expand the journal's industrial outreach and encourage research contributions from #Pharmaceutical companies. @BioconjChem
🎉 Welcome Apoorva Sarode (@ApoorvaSarode), the newest Topic Editor for Bioconjugate Chemistry!
Dr. Sarode is a Principal Scientist at Genentech, where she is one of the lead contributors in drug delivery research for novel modalities to access undruggable targets.
Welcome! 🎊